Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2018 Earnings

7NovConfirmed

Q1 2018

Q2 2018

Q3 2018

Q4 2018

-9.06

-7.56

-6.06

-4.57

Details

Expected EPS

-7.721824499999999

Actual EPS

-9.0647505

Surprise EPS

-1.34

Surprise Percent

+17.39%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -9.0647505 per share for Q4 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.